Recognition of atopic keratoconjunctivitis during treatment with dupilumab for atopic dermatitis - 07/06/21
Doi : 10.1016/j.jaad.2020.09.046
Justine Cheng, MD a, Lai Jiang, MD a, Nicole C. Morrow, MD a, Armin Avdic, MD, MS a, Janet A. Fairley, MD b, Jennifer J. Ling, MD a, Mark A. Greiner, MD a, ⁎ 
a Department of Ophthalmology and Visual Sciences, University of Iowa Carver College of Medicine, Iowa City, Iowa
b Department of Dermatology, University of Iowa Carver College of Medicine, Iowa City, Iowa
∗Reprint requests: Mark A. Greiner, MD, Cornea and External Diseases, Department of Ophthalmology and Visual Sciences, University of Iowa Carver College of Medicine, 200 Hawkins Dr, 11290A-PFP, Iowa City, IA 52242Cornea and External DiseasesDepartment of Ophthalmology and Visual SciencesUniversity of Iowa Carver College of Medicine200 Hawkins Dr, 11290A-PFPIowa CityIA52242
| Drs Ling and Greiner contributed equally to this article. |
|
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Determined by the University of Iowa IRB not to meet the regulatory definition of human subjects research (no. 201906723). |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 85 - N° 1
P. 265-267 - juillet 2021 Retour au numéro
Article précédent
- Growth of private equity in dermatology through acquisitions and new clinic formation, 2018 to 2019
- Kira Seiger, Elizabeth Tkachenko, Arash Mostaghimi
- Unna boot efficacy in dermatologic diseases
- Gabriella Santa Lucia, Alan Snyder, John Plante, Alexandra Ritter, Dirk Elston
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?